| Sarcoma Diagnosis and Treatment | Lifetime | 33 | GB 3 | 99.77 |
| Cardiac tumors and thrombi | Lifetime | 25 | GB 3 | 99.70 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 62 | GB 4 | 99.54 |
| Vascular Tumors and Angiosarcomas | Lifetime | 22 | GB 3 | 99.58 |
| Soft tissue tumor case studies | Lifetime | 56 | GB 4 | 99.16 |
| Bone Tumor Diagnosis and Treatments | Lifetime | 158 | GB 11 | 98.82 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 91 | GB 3 | 97.80 |
| Gastrointestinal disorders and treatments | Lifetime | 475 | GB 22 | 98.09 |
| CAR-T cell therapy research | Lifetime | 709 | GB 30 | 98.10 |
| Lymphoma Diagnosis and Treatment | Lifetime | 824 | GB 52 | 98.11 |
| Inflammatory mediators and NSAID effects | Lifetime | 439 | GB 44 | 97.42 |
| Cancer Treatment and Pharmacology | Lifetime | 779 | GB 35 | 97.95 |
| Tumors and Oncological Cases | Lifetime | 380 | GB 16 | 96.72 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 461 | GB 22 | 95.51 |
| Chemotherapy-related skin toxicity | Lifetime | 260 | GB 13 | 91.89 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 945 | GB 78 | 90.74 |
| Soft tissue tumors and treatment | Lifetime | 226 | GB 16 | 88.08 |
| Chromatin Remodeling and Cancer | Lifetime | 736 | GB 31 | 85.83 |
| Beetle Biology and Toxicology Studies | Lifetime | 843 | GB 21 | 44.84 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 4 | GB 1 | 99.80 |
| Cardiac tumors and thrombi | 2021-2025 | 4 | GB 1 | 99.15 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 13 | GB 1 | 99.46 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 4 | GB 1 | 99.08 |
| Gastrointestinal disorders and treatments | 2021-2025 | 41 | GB 2 | 97.65 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 142 | GB 5 | 98.50 |
| Bone Tumor Diagnosis and Treatments | 2021-2025 | 68 | GB 6 | 95.39 |
| Soft tissue tumor case studies | 2021-2025 | 20 | GB 1 | 95.60 |
| CAR-T cell therapy research | 2021-2025 | 501 | GB 8 | 96.93 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 413 | GB 25 | 96.34 |
| Cancer Diagnosis and Treatment | 2021-2025 | 427 | GB 19 | 82.63 |
| Neurofibromatosis and Schwannoma Cases | 2021-2025 | 281 | GB 14 | 86.60 |
| Musculoskeletal synovial abnormalities and treatments | 2021-2025 | 158 | GB 14 | 83.74 |
| Soft tissue tumors and treatment | 2021-2025 | 33 | GB 2 | 76.37 |
| Tumors and Oncological Cases | 2021-2025 | 597 | GB 20 | 68.80 |
| Histiocytic Disorders and Treatments | 2021-2025 | 530 | GB 13 | 49.44 |